Cargando…

The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science

The proposal by the European Chemicals Agency (ECHA) to ban over 12,000 per- and polyfluoroalkyl substances (PFAS) has sparked a debate about potential consequences for the economy, industry, and the environment. Although some PFAS are known to be harmful, a blanket ban may lead to significant probl...

Descripción completa

Detalles Bibliográficos
Autores principales: Spyrakis, Francesca, Dragani, Tommaso A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536631/
https://www.ncbi.nlm.nih.gov/pubmed/37755732
http://dx.doi.org/10.3390/toxics11090721
_version_ 1785112912915857408
author Spyrakis, Francesca
Dragani, Tommaso A.
author_facet Spyrakis, Francesca
Dragani, Tommaso A.
author_sort Spyrakis, Francesca
collection PubMed
description The proposal by the European Chemicals Agency (ECHA) to ban over 12,000 per- and polyfluoroalkyl substances (PFAS) has sparked a debate about potential consequences for the economy, industry, and the environment. Although some PFAS are known to be harmful, a blanket ban may lead to significant problems in attempting to replace PFAS-based materials for environmental transition, as well as in medical devices and everyday products. Alternative materials may potentially be less safe, as a rush to replace PFAS would reduce the time needed for toxicological analyses. Studies have shown that PFAS exhibit a diverse range of mechanisms of action, biopersistence, and bioaccumulation potential, and should thus not be treated as a single group. This is particularly true for the class of fluoropolymers. A targeted approach that considers the specific risks and benefits of each chemical may be more effective. Moreover, the proposed ban may also have unintended consequences for the environment as PFAS use is also associated with benefits such as reducing greenhouse-gas emissions and improving energy efficiency. Policymakers must carefully weigh up the potential consequences before making a final decision on the ban.
format Online
Article
Text
id pubmed-10536631
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105366312023-09-29 The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science Spyrakis, Francesca Dragani, Tommaso A. Toxics Review The proposal by the European Chemicals Agency (ECHA) to ban over 12,000 per- and polyfluoroalkyl substances (PFAS) has sparked a debate about potential consequences for the economy, industry, and the environment. Although some PFAS are known to be harmful, a blanket ban may lead to significant problems in attempting to replace PFAS-based materials for environmental transition, as well as in medical devices and everyday products. Alternative materials may potentially be less safe, as a rush to replace PFAS would reduce the time needed for toxicological analyses. Studies have shown that PFAS exhibit a diverse range of mechanisms of action, biopersistence, and bioaccumulation potential, and should thus not be treated as a single group. This is particularly true for the class of fluoropolymers. A targeted approach that considers the specific risks and benefits of each chemical may be more effective. Moreover, the proposed ban may also have unintended consequences for the environment as PFAS use is also associated with benefits such as reducing greenhouse-gas emissions and improving energy efficiency. Policymakers must carefully weigh up the potential consequences before making a final decision on the ban. MDPI 2023-08-22 /pmc/articles/PMC10536631/ /pubmed/37755732 http://dx.doi.org/10.3390/toxics11090721 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Spyrakis, Francesca
Dragani, Tommaso A.
The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science
title The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science
title_full The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science
title_fullStr The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science
title_full_unstemmed The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science
title_short The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science
title_sort eu’s per- and polyfluoroalkyl substances (pfas) ban: a case of policy over science
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536631/
https://www.ncbi.nlm.nih.gov/pubmed/37755732
http://dx.doi.org/10.3390/toxics11090721
work_keys_str_mv AT spyrakisfrancesca theeusperandpolyfluoroalkylsubstancespfasbanacaseofpolicyoverscience
AT draganitommasoa theeusperandpolyfluoroalkylsubstancespfasbanacaseofpolicyoverscience
AT spyrakisfrancesca eusperandpolyfluoroalkylsubstancespfasbanacaseofpolicyoverscience
AT draganitommasoa eusperandpolyfluoroalkylsubstancespfasbanacaseofpolicyoverscience